The agreement covering the compound petrelintide, announced by Roche on Wednesday, marks renewed efforts to catch up with weight-loss market leaders Novo Nordisk and Eli Lilly .
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback